Sam Altman’s September 2026 statements that an OpenAI IPO would be “ill-advised” this year due to the need to prioritize AI safety and alignment ahead of rapid capability gains have become the dominant factor shaping trader views. The CEO explicitly ruled out a 2026 listing, noting the company prefers to address alignment risks and potential regulatory needs as a private entity. In parallel, OpenAI is pursuing a $30 billion-plus private round targeting roughly $1.4 trillion valuation while reporting run-rate revenue near $40 billion. These developments have shifted market-implied odds sharply lower for any near-term debut, with upcoming catalysts including further safety announcements, competitive moves from labs such as Anthropic, and any updates on 2027 timing.